Skip to main content
. Author manuscript; available in PMC: 2023 Dec 1.
Published in final edited form as: ASAIO J. 2022 Feb 27;68(12):1450–1458. doi: 10.1097/MAT.0000000000001690

Figure 2.

Figure 2.

Distribution of initial pathogen (gram-positive, gram-negative, polymicrobial, culture-negative) stratified by: (A) chronic antibiotic suppression (CAS) use vs. (B) not (No CAS). (C) Antibiotic distribution among patients treated with CAS. CAS, chronic antibiotic suppression: Gram-positive: 21 methicillin-sensitive Staphylococcus aureus, 7 methicillin-resistant Staphylococcus aureus, 2 Diphtheroids, 1 Enterococcus faecalis, 3 coagulase-negative staphylococcus. Gram-negative: 15 Pseudomonas aeruginosa, 6 Serratia marcescens, 4 Klebsiella pneumoniae, 2 Stenotrophomonas maltophilia, 1 Achromobacter xylosoxidans, 1 Acinetobacter baumannii complex, 1 Burkholderia cepacia complex, 1 Enterobacter cloacae, 1 Escherichia coli, 1 Serratia liquefaciens. No CAS: Not on Chronic Antibiotic Suppression: Gram-positive: 7 methicillin-sensitive Staphylococcus aureus, 2 methicillin-resistant Staphylococcus aureus, 1 coagulase-negative staphylococcus, 1 Corynebacterium striatum, 1 Streptococcus viridans. Gram negative: 5 Serratia marcescens, 3 Pseudomonas aeruginosa, 2 Enterobacter cloacae, 2 Enterobacter aerogenes, 2 Stenotrophomonas maltophilia, 1 Acinetobacter baumannii complex, 1 Acinetobacter oitti, 1 Klebsiella pneumoniae